Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
300 participants
INTERVENTIONAL
2021-03-30
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia
NCT04951362
Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis
NCT01391286
Evaluation of Lacrimal Punctal Changes by Anterior Segment Optical Coherence Tomography AS-OCT After Topical Combined Antibiotics and Steroids Treatment in Cases of Inflammatory Punctual Stenosis
NCT05028907
Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases
NCT05337332
Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
NCT04418999
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Time to recover of Anosmia and / or ageusia and early corticosteroid use
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early CS
early use of dexamethasone as early as the laboratory confirmation of inflammation.
Early-Dexamethasone
early use of dexamethasone as early as laboratory evidence of high inflammatory markers
Late CS
Dexamethasone is to be used lately upon the deterioration of cases
Late dexamethazone
Use of dexamethasone on deterioration of the cases with increased severity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early-Dexamethasone
early use of dexamethasone as early as laboratory evidence of high inflammatory markers
Late dexamethazone
Use of dexamethasone on deterioration of the cases with increased severity
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age more than or equal to 18 years
* Mild to moderate severity
Exclusion Criteria
* Any contra-indication for the interventional drug
* Mentally disabled cases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ClinAmygate
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emad R Issak, MD
Role: STUDY_DIRECTOR
Assalam Clinics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asalam
Maadi, Cairo Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Spoorenberg SM, Deneer VH, Grutters JC, Pulles AE, Voorn GP, Rijkers GT, Bos WJ, van de Garde EM. Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. Br J Clin Pharmacol. 2014 Jul;78(1):78-83. doi: 10.1111/bcp.12295.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR0013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.